Cured or Consumed? How Kidney Cancer Patients Experience Survival
A recent presentation at the 2025 International Kidney Cancer Symposium highlighted a critical yet often overlooked aspect of kidney cancer care: the difference between patients who feel “cured” and those who are “consumed” by their disease, revealing that while most patients with localized kidney cancer have high cancer-specific survival (up to 95% for stage 1), surveys show a striking gap between doctor and patient perceptions of cure, with many patients unsure of their long-term outlook despite favorable statistics.
